Black Rock Inc. Tg Therapeutics, Inc. Transaction History

Black Rock Inc.

$4.23 Trillion
Q1 2024

A detailed history of Black Rock Inc. transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 10,843,502 shares of TGTX stock, worth $193 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

10,843,502

Previous 10,768,163 0.7%

Holding current value

$193 Million

Previous $184 Million 10.33%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$13.02 - $21.3 $980,913 - $1.6 Million	75,339 Added 0.7%	10,843,502 $165 Million
Q4 2023 Feb 13, 2024	BUY	$6.68 - $18.81 $5.22 Million - $14.7 Million	781,216 Added 7.82%	10,768,163 $184 Million
Q3 2023 Nov 13, 2023	BUY	$8.36 - $26.5 $580,886 - $1.84 Million	69,484 Added 0.7%	9,986,947 $83.5 Million
Q2 2023 Aug 11, 2023	BUY	$15.48 - $35.0 $16.5 Million - $37.4 Million	1,067,763 Added 12.07%	9,917,463 $246 Million
Q1 2023 May 12, 2023	SELL	$10.23 - $19.34 $2.91 Million - $5.5 Million	-284,247 Reduced 3.11%	8,849,700 $133 Million

Q4 2022 Feb 13, 2023	BUY	$5.01 - $11.83 $495,473 - $1.17 Million	98,897 Added 1.09%	9,133,947 $108 Million
Q3 2022 Nov 14, 2022	SELL	$4.57 - $8.4 $1.04 Million - $1.91 Million	-227,275 Reduced 2.45%	9,035,050 $53.5 Million
Q2 2022 Aug 12, 2022	BUY	$3.74 - $10.66 $1.22 Million - $3.48 Million	326,747 Added 3.66%	9,262,325 $39.4 Million
Q1 2022 May 12, 2022	BUY	$7.81 - $20.45 $260,955 - $683,295	33,413 Added 0.38%	8,935,578 $85 Million
Q4 2021 Feb 10, 2022	BUY	$15.2 - $35.51 $650,225 - $1.52 Million	42,778 Added 0.48%	8,902,165 $169 Million
Q3 2021 Nov 09, 2021	BUY	$21.78 - $40.45 $11 Million - $20.5 Million	507,028 Added 6.07%	8,859,387 $295 Million
Q2 2021 Aug 11, 2021	BUY	$32.5 - $48.96 $271 Million - $409 Million	8,352,359 New	8,352,359 $324 Million

Others Institutions Holding TGTX

# of Institutions

269

Shares Held

87.7M

Call Options Held

2.72M

Put Options Held

1.74M

View Full List

About TG THERAPEUTICS, INC.

Ticker TGTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 145,274,000
Market Cap $2.58B
Description
TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...

More about TGTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account